N61.20 Granulomatous mastitis, unspecified breast

Name of the Condition

• Granulomatous Mastitis, Unspecified Breast
• ICD-10 Code: N61.20

Summary

Granulomatous mastitis is a rare inflammatory condition of the breast characterized by the formation of granulomas, which are clusters of immune cells. It typically presents with a painful, firm mass or swelling in the breast, often accompanied by skin changes or nipple discharge. The condition is non-infectious and may mimic breast cancer, requiring careful evaluation to distinguish it from other breast disorders.

Causes

The exact cause of granulomatous mastitis is not fully understood, but it is thought to involve an abnormal immune response. Possible triggers include prior trauma, surgery, or inflammation, though many cases occur without a clear preceding event. The condition is not associated with infection and is distinct from bacterial mastitis.

Risk Factors

• Recent breast trauma or surgery: Physical injury or surgical procedures may precede the onset.
• Autoimmune conditions: Underlying immune system disorders may increase susceptibility.
• Hormonal factors: Some cases are linked to changes in hormone levels, such as those occurring postpartum.
• Smoking: Tobacco use has been identified as a potential risk factor in some studies.

Symptoms

• Painful, firm breast mass or lump.
• Skin redness, warmth, or thickening.
• Nipple discharge, which may be bloody or clear.
• Swelling or enlargement of the affected breast.
• Fever or general malaise in some cases.

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging (e.g., mammography or ultrasound), and tissue biopsy. The biopsy is critical to confirm the presence of granulomas and rule out malignancy or infection. Blood tests may be performed to assess for underlying conditions, but definitive diagnosis relies on histopathological examination.

Treatment Options

Treatment is tailored to the individual and may include observation for mild cases, anti-inflammatory medications, or corticosteroids to reduce inflammation. In some instances, surgical drainage or excision of the affected tissue is necessary. Antibiotics are not typically effective, as the condition is non-infectious.

Prognosis and Follow-Up

Most patients respond well to treatment, with symptoms improving over weeks to months. However, recurrence is possible, and regular follow-up is recommended to monitor for changes. Long-term outcomes are generally favorable, though some individuals may experience persistent symptoms or require additional interventions.

Complications

Potential complications include chronic pain, scarring, or recurrence of the mass. Rarely, the condition may lead to skin ulceration or fistula formation. Early diagnosis and appropriate management help minimize these risks.

Lifestyle & Prevention

While no specific preventive measures exist, maintaining breast health through regular self-exams and prompt evaluation of any new breast changes is advisable. Avoiding smoking and managing underlying health conditions may reduce risk in susceptible individuals.

When to Seek Professional Help

Seek medical attention if you notice a new breast lump, persistent pain, skin changes, or nipple discharge. Prompt evaluation is important to rule out serious conditions like cancer or infection and to initiate appropriate treatment.

Tips for Medical Coders

When coding for granulomatous mastitis, use N61.20 for unspecified breast involvement. Documentation should clearly indicate the absence of infection and specify the affected breast (e.g., left, right, or bilateral) if known. Ensure clinical notes support the diagnosis, as granulomatous mastitis may require differentiation from other inflammatory or neoplastic breast conditions.